Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
  2. >
  3. Stock
  4. >
  5. MANH
stocks logo

MANH

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
263.62M
-0.64%
1.126
-4.53%
269.92M
+1.21%
1.164
-13.75%
265.43M
+3.76%
1.122
-4.09%
Estimates Revision
The market is revising Downward the revenue expectations for Manhattan Associates, Inc. (MANH) for FY2025, with the revenue forecasts being adjusted by -0.29% over the past three months. During the same period, the stock price has changed by 9.04%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.29%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.54%
In Past 3 Month
Stock Price
Go Up
up Image
+9.04%
In Past 3 Month
9 Analyst Rating
up Image0
Wall Street analysts forecast MANH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MANH is 197.00 USD with a low forecast of 177.00 USD and a high forecast of 212.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
3 Hold
0 Sell
Moderate Buy
up Image0
Current: 191.520
sliders
Low
177.00
Averages
197.00
High
212.00
up Image0
Current: 191.520
sliders
Low
177.00
Averages
197.00
High
212.00
Redburn Atlantic
Buy
to
Neutral
downgrade
$270 -> $200
2025-06-10
Reason
Redburn Atlantic
Price Target
$270 -> $200
2025-06-10
downgrade
Buy
to
Neutral
Reason
Redburn Atlantic downgraded Manhattan Associates to Neutral from Buy with a price target of $200, down from $270. The company remains highly exposed to discretionary professional services, and three factors will sustain pressure on the services - Manhattan's cloud product should require less support than on-premise, system integrators are more familiar with the company's products and offer cheaper rates, and the customer base will continue to be prudent on discretionary spend given macro uncertainty, the analyst tells investors in a research note. As such, Redburn reduced estimates and downgraded the shares.
Baird
Joe Vruwink
Outperform
maintain
$197 -> $212
2025-05-21
Reason
Baird
Joe Vruwink
Price Target
$197 -> $212
2025-05-21
maintain
Outperform
Reason
Baird analyst Joe Vruwink raised the firm's price target on Manhattan Associates to $212 from $197 and keeps an Outperform rating on the shares. The firm updated its model following the Momentum 2025 Conference.
DA Davidson
Buy
maintain
$200 -> $225
2025-05-21
Reason
DA Davidson
Price Target
$200 -> $225
2025-05-21
maintain
Buy
Reason
DA Davidson raised the firm's price target on Manhattan Associates to $225 from $200 and keeps a Buy rating on the shares after its Momentum conference presentation. The firm expects the company will make concerted investments to increase adoption of its entire product portfolio and accelerate implementations to deliver ROI faster, the analyst tells investors in a research note.
Truist
Buy
maintain
$190 -> $210
2025-05-21
Reason
Truist
Price Target
$190 -> $210
2025-05-21
maintain
Buy
Reason
Truist raised the firm's price target on Manhattan Associates to $210 from $190 and keeps a Buy rating on the shares. The firm is "incrementally confident" in the company's long-term fundamentals, "sustained strong" cloud subscriber revenue growth and cash flow performance after attending the Manhattan Associates Momentum conference in Las Vegas. Truist says the company is "making relatively quick progress" and moving well beyond generative artificial intelligence based chat interface use cases into the world of agentic AI use cases.
DA Davidson
Gil Luria
Strong Buy
Maintains
$195 → $200
2025-04-23
Reason
DA Davidson
Gil Luria
Price Target
$195 → $200
2025-04-23
Maintains
Strong Buy
Reason
Truist Securities
Terry Tillman
Strong Buy
Maintains
$180 → $190
2025-04-23
Reason
Truist Securities
Terry Tillman
Price Target
$180 → $190
2025-04-23
Maintains
Strong Buy
Reason
Truist raised the firm's price target on Manhattan Associates to $190 from $180 and keeps a Buy rating on the shares. The firm notes Q1 results were solid, with upside across the model. Truist says Manhattan Associates remains top quartile performer on SaaS revenue growth, operating margin, and free cash flow, and it expects top quartile performance to continue in spite of ongoing macro volatility.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Manhattan Associates Inc (MANH.O) is 41.92, compared to its 5-year average forward P/E of 59.42. For a more detailed relative valuation and DCF analysis to assess Manhattan Associates Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
59.42
Current PE
41.92
Overvalued PE
71.49
Undervalued PE
47.35

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
43.88
Current EV/EBITDA
32.25
Overvalued EV/EBITDA
51.98
Undervalued EV/EBITDA
35.79

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PS
12.31
Current PS
10.95
Overvalued PS
14.35
Undervalued PS
10.27

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

MANH News & Events

Events Timeline

(ET)
2025-05-28
05:14:10
Manhattan Associates enters expanded go-to-market partnership with Google Cloud
select
2025-05-13 (ET)
2025-05-13
10:04:38
Manhattan Associates board chairman John Huntz to retire, Eddie Capel to succeed
select
2025-04-22 (ET)
2025-04-22
16:09:16
Manhattan Associates raises FY25 EPS view to $4.54-$4.64 from $4.45-$4.55
select
Sign Up For More Events
Sign Up For More Events

News

Preview
3.5
06-17Newsfilter
Giant Eagle's Largest Facility Successfully Implements Manhattan Active® Warehouse Management, Advancing Multi-Site Rollout
  • Giant Eagle Implements Manhattan Active Warehouse Management: Giant Eagle has successfully implemented Manhattan Active Warehouse Management at its largest facility in Ohio, marking the fifth step in its cloud migration plan, with plans to complete the transition by September 2025. The new system has already shown strong performance, processing hundreds of thousands of cases in its first week.

  • Partnership and Future Plans: Both Giant Eagle and Manhattan Associates emphasize their successful partnership, highlighting the seamless implementation and operational improvements. Giant Eagle is also set to implement Manhattan Active Transportation Management to further optimize its logistics operations.

Preview
7.0
06-16Globenewswire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Blue Ridge Bankshares, Inc. (NYSE: BRBS); Manhattan Associates, Inc. (NASDAQ: MANH); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
  • Blue Ridge Bankshares Investigation: Shareholders of Blue Ridge Bankshares who purchased shares before February 3, 2023, can seek corporate reforms and a court-approved incentive award due to a settled securities fraud complaint alleging misleading financial statements.

  • Other Companies Under Investigation: Manhattan Associates, Treace Medical Concepts, and Virtu Financial are also facing investigations for potential securities fraud, with shareholders encouraged to contact legal representatives for possible claims related to misleading statements and corporate governance issues.

Preview
7.0
06-13Globenewswire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Manhattan Associates, Inc. (NASDAQ: MANH); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
  • DoubleVerify Holdings Investigation: Grabar Law Office is investigating potential breaches of fiduciary duties by DoubleVerify's officers and directors related to undisclosed issues affecting the company's advertising services and financial performance, as alleged in a securities fraud class action complaint.

  • Manhattan Associates and Treace Medical Investigations: Similar investigations are underway for Manhattan Associates and Treace Medical Concepts regarding misleading statements about their revenue forecasts and product demand, with shareholders encouraged to seek corporate reforms and potential returns.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Manhattan Associates Inc (MANH) stock price today?

The current price of MANH is 191.52 USD — it has decreased -0.58 % in the last trading day.

arrow icon

What is Manhattan Associates Inc (MANH)'s business?

Manhattan Associates, Inc. develops, sells, deploys, services and maintains software solutions designed to manage supply chains, inventory and omnichannel operations for retailers, wholesalers, manufacturers, logistics providers and other organizations. It operates in North and Latin America; Europe, the Middle East and Africa (EMEA); and the Asia Pacific (APAC) regions. It provides companies with the tools needed to manage distribution and optimize transportation costs throughout their entire commercial network. Its solutions consist of software, services, and hardware, which coordinate people, workflows, assets, events, and tasks holistically across the functions linked in a supply chain from planning through execution. These solutions help to coordinate the actions, data exchange, and communication of participants in supply chain ecosystems, such as manufacturers, suppliers, distributors, trading partners, transportation providers, among others.

arrow icon

What is the price predicton of MANH Stock?

Wall Street analysts forecast MANH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MANH is 197.00 USD with a low forecast of 177.00 USD and a high forecast of 212.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Manhattan Associates Inc (MANH)'s revenue for the last quarter?

Manhattan Associates Inc revenue for the last quarter amounts to 262.79M USD, increased 3.24 % YoY.

arrow icon

What is Manhattan Associates Inc (MANH)'s earnings per share (EPS) for the last quarter?

Manhattan Associates Inc. EPS for the last quarter amounts to 0.85 USD, decreased -1.16 % YoY.

arrow icon

What changes have occurred in the market's expectations for Manhattan Associates Inc (MANH)'s fundamentals?

The market is revising Downward the revenue expectations for Manhattan Associates, Inc. (MANH) for FY2025, with the revenue forecasts being adjusted by -0.29% over the past three months. During the same period, the stock price has changed by 9.04%.
arrow icon

How many employees does Manhattan Associates Inc (MANH). have?

Manhattan Associates Inc (MANH) has 4690 emplpoyees as of June 18 2025.

arrow icon

What is Manhattan Associates Inc (MANH) market cap?

Today MANH has the market capitalization of 11.63B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free